Apitegromab (Anti-GDF8 / Myostatin)

Apitegromab (Anti-GDF8 / Myostatin) is a fully human monoclonal antibody that binds to human promyostatin and latent myostatin with a high degree of specificity, without binding to mature myostatin and other closely related growth factors. Apitegromab can be used for the research of neuromuscular disease including spinal muscular atrophy. MW: 145.5 KD.
Supplier Selleck Chemicals
Product # A2482
Sku # A2482-1mg*5
Pricing 1mg*5, $790.00
Feedback